Skip to main content

Table 2 Costs of CHC treatment

From: Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6

Cost parameters

Mean

Standard error

Distribution

Ref.

Medication, laboratory and diagnostic tests costs

 Pegylated interferon alfa-2a + Ribavirin (per week)

3,150

630

Gamma

[35]

 Pegylated interferon alfa-2b + Ribavirin (per week)

3,150

630

Gamma

[35]

 Investigation and monitoring

16,277

3,255

Gamma

[34]

Direct medical cost for complication treatment

 Costs of chronic HCV infection (per year)

65,640

19,723

Gamma

[33]

 Costs of compensated cirrhosis (per year)

73,532

18,605

Gamma

[33]

 Costs of decompensated cirrhosis (per year)

138,141

18,996

Gamma

[33]

 Costs of hepatocellular carcinoma (per year)

168,899

11,601

Gamma

[33]

Direct non-medical cost for complication treatment

 Costs of chronic HCV infection (per year)

4,303

430.3

Gamma

[33, 34]

 Costs of compensated cirrhosis (per year)

4,216

421.6

Gamma

[33, 34]

 Costs of decompensated cirrhosis (per year)

5,823

582.3

Gamma

[33, 34]

 Costs of hepatocellular carcinoma (per year)

9,516

951.6

Gamma

[33, 34]